Anticoagulation monitoring by an anticoagulation service is more cost-effective than routine physician care

Journal of Vascular Surgery

Volumn 54, Issue 5, 2011, Pages 1404-1407

  Aziz, Faisal ^a   Corder, Mary ^b   Wolffe, Jaclyn ^b   Comerota, Anthony J ^a,c  

^a Jobst Vascular Institute   (United States)

^b Paramount Health Care   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K;

ANTICOAGULANT THERAPY; ARTICLE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; EMERGENCY WARD; HEALTH CARE COST; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL CARE; MORBIDITY; PATIENT MONITORING; PRIORITY JOURNAL;

ANTICOAGULANTS; CHI-SQUARE DISTRIBUTION; CLINICAL PROTOCOLS; COST SAVINGS; COST-BENEFIT ANALYSIS; DRUG MONITORING; EMERGENCY SERVICE, HOSPITAL; HEALTH CARE COSTS; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; NURSE PRACTITIONERS; NURSING SERVICES; ODDS RATIO; OHIO; PHYSICIANS; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; TIME FACTORS; VITAMIN K;

EID: 80054865805     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2011.05.021     Document Type: Article

References (14)

1. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):204S-33S. (Pubitemid 39297955)
2. Wolf PA, Clagett GP, Easton JD, Goldstein LB, Gorelick PB, Kelly-Hayes M, et al. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 1999;30:1991-4.
3. Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med 2003;348:1425-34. (Pubitemid 36407171)
4. Wysowski DK, Nourjah P, Swartz L. Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med 2007;167:1414-9. (Pubitemid 47052441)
5. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med 1998;158:1641-7. (Pubitemid 28371187)
6. Chamberlain MA, Sageser NA, Ruiz D. Comparison of anticoagulation clinic patient outcomes with outcomes from traditional care in a family medicine clinic. J Am Board Fam Pract 2001;14:16-21. (Pubitemid 33605759)
7. Gray DR, Garabedian-Ruffalo SM, Chretien SD. Cost-justification of a clinical pharmacist-managed anticoagulation clinic. Ann Pharmacother 2007;41:496-501.
8. Hylek EM, Skates SJ, Sheehan MA, Singer DE. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 1996;335:540-6. (Pubitemid 26272308)
9. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 1994;120:897-902. (Pubitemid 24179151)
10. Gitter MJ, Jaeger TM, Petterson TM, Gersh BJ, Silverstein MD. Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnesota. Mayo Clin Proc 1995;70:725-33.
11. Palareti G, Manotti C, DAngelo A, Pengo V, Erba N, Moia M, et al. Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study: ISCOAT study group (Italian Study on Complications of Oral Anticoagulant Therapy). Thromb Haemost 1997;78:1438-43. (Pubitemid 27519386)
12. Forfar JC. Prediction of hemorrhage during long-term oral coumarin anticoagulation by excessive prothrombin ratio. Am Heart J 1982;103:445-6. (Pubitemid 12178736)
13. Petty GW, Lennihan L, Mohr JP, Hauser WA, Weitz J, Owen J, et al. Complications of long-term anticoagulation. Ann Neurol 1988;23:570-4.
14. Fihn SD, McDonell M, Martin D, Henikoff J, Vermes D, Kent D, et al. Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group. Ann Intern Med 1993;118:511-20. (Pubitemid 23085793)